EU Food Information Regulation (FIR) vs FDA: Key Differences for Global CPG Brands

Launching in both US and EU markets? These 12 labeling differences could delay your launch by months. Understanding where EU Regulation 1169/2011 and FDA 21 CFR Part 101 diverge — not just in what they require, but in how they require it, is what separates a smooth dual-market launch from a costly revision cycle.

Key Takeaways

• EU FIR and FDA share the same consumer protection intent but use fundamentally different frameworks: the EU mandates specific x-height minimums, QUID declarations, and origin labeling that FDA does not require in the same form.
• Allergen declaration rules differ in format, trigger thresholds, and placement requirements — a single label cannot satisfy both without deliberate dual-market design.
• Label errors accounted for 45.5% (192 of 422) of US food recall events in 2024, and 83.85% of label errors were undeclared allergens, the exact categories where EU and US rules diverge most sharply.
• Managing dual-market compliance manually creates version control risk; simultaneous AI-driven validation against both frameworks reduces the window for error.

Why Multi-Market Food Labeling Is Harder Than It Looks?

Here are some most common issues faced by brands while expanding their products in a EU market.

The divergence runs deeper than font size

The EU requires a minimum x-height of 1.2mm for mandatory text (0.9mm for packages under 80cm²), while FDA specifies minimum type sizes in points under 21 CFR 101.2. These are not the same measurement system applied to the same requirement — they reflect different design philosophies. A label that clears FDA review can still fail EU legibility standards. The EU framework (Regulation 1169/2011) was built around single internal market harmonisation; the FDA framework evolved from the Nutrition Labeling and Education Act. Both are comprehensive, both actively enforced, and they are not interoperable without deliberate multi-market design.

The cost of getting it wrong

Label errors accounted for 45.5% of US food recall events in 2024 (192 of 422 recalls), and undeclared allergens alone accounted for nearly 34% of all U.S. food recalls in 2024. These are the exact label categories where US and EU rules diverge most, allergen declaration format, emphasis requirements, and placement rules.

These are preventable errors, and they occur most often when compliance teams manage US and EU requirements through separate, disconnected review processes.

EU FIR vs FDA: The 12 Core Labeling Differences

1. Mandatory Information and Layout

FDA under 21 CFR 101.1 requires the principal display panel (PDP) to carry the statement of identity and net quantity. The information panel carries nutrition facts, ingredients, allergens, and manufacturer details. EU FIR Article 13 requires all mandatory particulars to appear in the same field of vision where possible , a concept that does not map cleanly onto FDA's PDP/information panel distinction.

In Practice: EU regulators interpret "same field of vision" strictly. If mandatory particulars are placed on a secondary panel that requires rotating the package, some national authorities will flag non-compliance. Design your EU label so all mandated fields appear on a single face wherever dimensions allow.

2. Nutrition Labeling Format

The FDA Nutrition Facts Panel (21 CFR 101.9) follows a specific tabular format with mandatory bold text for key nutrients and includes added sugars and actual amounts for Vitamin D and Potassium.

EU FIR Article 30 requires energy, fat, saturates, carbohydrate, sugars, protein, and salt — notably salt, not sodium — expressed in both kJ and kcal. Energy must appear in both units; the EU declaration can use a linear format on small packages. Your data entry, formatting specs, and print validation must treat these as entirely distinct fields.

3. Allergen Declaration Rules

FDA under 21 CFR 101.4(b) and the FASTER Act requires declaration of 9 major allergens (including sesame, added in 2023) by common name — either in the ingredient list or in a "Contains" statement.

EU FIR Annex II lists 14 allergens, adding lupin, molluscs, and sulphur dioxide/sulphites. Critically, EU rules require allergens to be emphasised through a different font, style, or background colour within the ingredient list itself. A "Contains" statement alone does not satisfy EU FIR.

4. Ingredient List and QUID Declarations

Both frameworks require ingredients listed in descending order of predominance by weight.

The EU adds the Quantitative Ingredient Declaration (QUID) under FIR Article 22 — if an ingredient appears in the product name or is emphasised on the label, its percentage must be declared. If your label says "Tomato Sauce with Basil," the basil percentage must appear in the ingredient list or adjacent to the product name. FDA has no equivalent. This single difference routinely forces label copy reformulation for EU entries when discovered late in artwork approval.

5. Country of Origin and Provenance Claims

FDA origin labeling is product-specific and fragmented, COOL requirements under the Agricultural Marketing Act apply to fresh produce and seafood, but not most processed foods.

EU FIR Article 26 requires mandatory origin for fresh pork, lamb, goat, poultry, honey, olive oil, and fresh fruit and vegetables. For other foods, origin must be declared when its omission would materially mislead consumers. A geographic flavour claim in the EU may require substantiation of the primary ingredient's source.

6. Net Weight and Volume Declarations

FDA net quantity statements (21 CFR 101.105) must include both metric and US customary units.

EU FIR Article 23 requires metric only. Dual-market packages must carry both, but placement and type size requirements also differ, a layout challenge for small-format packaging.

7. Health Claims and Functional Claims

FDA allows authorised health claims, qualified health claims (with disclaimer language), and structure/function claims.

The EU operates under Regulation (EC) No 1924/2006, which maintains an authorised claims register — if a claim is not on the register, it cannot be used. There is no "qualified health claim" pathway in the EU. A claim fully compliant on US shelves may be prohibited in the EU with no compliant alternative. Verify claims at the earliest stage of copy development.

8. Date Marking

FDA requires a "use by" date only on infant formula (21 CFR 107.20); other date marking is voluntary.

EU FIR Articles 24 and 25 require either a "best before" date for minimum durability or a "use by" date for perishable products, with a specified date format (DD/MM/YYYY for perishables). Non-compliance here is regularly flagged by import authorities, particularly in Germany and France.

9. PFAS Restrictions in Packaging Materials (EU, August 2026)

The EU is implementing strict PFAS controls on food contact packaging effective August 2026. Products using PFAS-containing grease-resistant packaging above defined concentration thresholds will not be compliant for EU sale after that date.

FDA has no equivalent restriction currently in force. If your product uses PFAS-containing food contact materials — common in microwave popcorn bags and some supplement packaging — material qualification and specification changes must begin now, not during label artwork review.

10. Serving Size and Reference Amounts

FDA serving sizes are based on standardised Reference Amounts Customarily Consumed (RACCs) under 21 CFR 101.12. EU FIR allows per-portion declarations, but the portion size is manufacturer-set. US and EU nutrition panels for the same product will often show different per-serve values — not because the formulation differs, but because the reference unit does. Auditors and import officials sometimes flag this without understanding the regulatory basis.

11. Mandatory Symbols and Recycling Information

EU FIR and associated packaging regulations require recyclability symbols and environmental labeling that have no FDA equivalent. EU Packaging and Packaging Waste Regulation updates require specific symbols for packaging material types across member states. Manual checkers frequently miss these entirely when reviewing artwork built to US template specifications.

12. Language Requirements

FDA requires English as the primary language for mandatory information. The EU requires the official language(s) of the member state(s) where the product is sold. A product sold across Germany and the Netherlands requires both German and Dutch mandatory text. Multi-country EU distribution requires market-specific label variants — each requiring its own compliance review.

EU vs FDA Compliance Matrix: Side-by-Side Reference

How Compliance Teams Should Manage Dual-Market Label Reviews?

Run parallel validation, not sequential reviews

When label artwork is revised to address an FDA finding, that change needs to be checked against EU requirements simultaneously — and vice versa. Teams running sequential reviews (FDA first, then EU, or through separate external parties) routinely find that a correction for one market creates a violation in the other. Simultaneous validation against both frameworks from the first draft is the only approach that reliably prevents this.

Use AI agents to handle both frameworks in a single workflow

GoVisually's US FDA Regulatory Agent (v3.0) validates FDA mandatory fields, allergen declarations, ingredient order, and nutrition facts — citing specific 21 CFR sections for every finding. The EU Regulatory Agent (v1.0) runs alongside it, checking QUID declarations, allergen emphasis, origin labeling, recyclability symbols, and multi-language requirements. Both agents run within a single AI Playbook on file upload, with findings displayed as visual overlays directly on the label artwork — no manual reconciliation of two separate reports.

Manage multi-market portfolios with metadata-driven filtering

For teams managing 50+ SKUs across dual markets, GoVisually's custom fields let you tag each proof with Target Market, Regulatory Status, Language Variant, and Launch Date — then filter to show only "EU labels pending allergen sign-off" or "US labels with open Critical findings." That kind of portfolio-level visibility is what makes dual-market compliance scalable without additional headcount.

Important: Setting up and maintaining dual-market knowledge bases, regulatory rule sets, and agent configurations requires either a dedicated in-house compliance team or significant ongoing effort. That's why it's worth subscribing to a globally recognized, trusted solution — GoVisually is an award-winning platform recognized at the World Agri-FoodTech Startup Challenge at Gulfood — The World's Biggest F&B Event, making it a proven choice for multi-market CPG compliance.

Conclusion

The EU FIR and FDA frameworks are both comprehensive and actively enforced — the compliance challenge is that they're clear in different ways, requiring different design decisions, data inputs, and review processes. Teams that treat dual-market labeling as "US label plus some EU adjustments" will keep hitting QUID declarations, allergen emphasis requirements, and PFAS material restrictions late in the process, where corrections are most expensive.

The fix is straightforward: build dual-market requirements into the label brief, not the artwork review. When both frameworks are addressed in the first draft, the revision cycle shrinks dramatically. Running simultaneous FDA and EU validation through AI agents — with findings surfaced directly on label artwork and a full audit trail — changes the risk profile of a multi-market launch without replacing the regulatory expertise required to resolve what the agents surface.

Validate labels against FDA, EU, Health Canada, and APAC regulations in a single platform, book a demo here to see GoVisually's multi-market compliance tool in action.

FAQ

What is the minimum font size for mandatory text on EU food labels?

EU FIR Article 13(2) requires an x-height of at least 1.2mm (0.9mm for packages under 80cm²). This differs from FDA, which specifies a minimum of 1/16 inch for most mandatory text under 21 CFR 101.2 — a different measurement system with different design implications.

Does the EU require a "Contains" allergen statement like the FDA?

No. The EU requires allergens to be emphasised within the ingredient list itself — via bold text, different font, or contrasting background under FIR Annex II. A standalone "Contains" statement satisfies FDA but fails EU FIR allergen compliance, even if every allergen is correctly identified.

What is QUID and does it apply to products sold in the US?

QUID (Quantitative Ingredient Declaration) is an EU-only requirement under FIR Article 22. It requires you to declare the percentage of an ingredient when it features in the product name, is visually emphasised, or characterises the food. The FDA has no equivalent.

Does the EU allow qualified health claims the way the FDA does?

No. The EU regulates health claims under Regulation (EC) No 1924/2006 — claims must appear on the EU authorised register to be permitted. There is no EU equivalent to the FDA's qualified health claim pathway. If your claim isn't on the register, it cannot appear on EU packaging in any form.

What is the EU PFAS packaging deadline and does it affect labeling?

The EU's PFAS restrictions for food contact packaging take effect August 2026. It affects packaging materials, not label text — but CPG teams must update packaging specifications and material qualification documentation before that date or lose EU market access regardless of label compliance.

Can a single label design satisfy both FDA and EU requirements?

In principle, yes — but it requires metric plus US customary units, 14-allergen coverage emphasised in the ingredient list, both kJ and kcal on the nutrition panel, and QUID declarations where required. In practice, most brands maintain market-specific variants, since member state language requirements alone make a truly universal EU label impractical.